Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
193.00    0.40 (0.21%)
Bid:
193.00
Ask:
193.60
Spread: 0.60 (0.311%)
Market Cap: £515.46m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Update on P&H contract and current trading

13 Dec 2021 07:00

RNS Number : 3574V
Costain Group PLC
13 December 2021
 

 

Costain Group PLC

13 December 2021

 

 

Update on Peterborough & Huntingdon contract and current trading

 

Costain is providing an update on the adjudication process regarding the legacy Peterborough and Huntingdon contract dispute. In addition, we are providing an update to guidance and re-confirm that full year adjusted operating profit is expected to be in line with market expectations. Year end net cash, before any period end timing benefits, will now be ahead of market expectations at around £100m.

 

We have now received several adjudication decisions, the most recent and material of which was received on 10 December 2021. In this claim, the adjudicator found in our favour on principle in respect of three out of the four compensation events.

 

However, he has chosen not to determine the financial amounts in respect of these compensation events. We will pursue a financial settlement with National Grid in respect of these compensation events. As not all compensation events have been decided in our favour, we now expect there to be an overall cash outflow in respect of the contract.

 

Under the terms of the termination agreement with National Grid, there is an expected requirement to make a payment of £53.5m in January 2022, which now represents the maximum cash outflow under the contract. Given the recent adjudication decision, we have an entitlement to recover a proportion of this payment and will be discussing the timing and amount with National Grid. The payment, if made, will not affect our banking arrangements and we will continue to have a strong balance sheet that enables us to deliver our business plan. There will be an associated charge to the income statement for the current financial year reflecting such payment.

 

We are making good progress on our journey to transform the business, reduce risk and improve returns. This, combined with the considerable government investment in infrastructure, allows us to look forward with confidence.

 

Our next scheduled update will be the 2021 full year results, which are due to be announced on 9 March 2022.

 

 

Enquiries

 

Investors and analysts

Louise Bryant, Costain

 

 

+44 7813 210 809

Financial media

Tim Rowntree, MHP

Peter Hewer, MHP

 

+44 203 128 8771

Costain@mhpc.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The person responsible for this announcement on behalf of Costain is Louise Bryant, Group Director of Communications & Investor Relations.

 

Background to the Peterborough & Huntingdon contract

On 29 June 2020, we announced that a termination and settlement agreement had been reached with National Grid to cease work on the Peterborough & Huntingdon gas compressor project following a significant change in scope. The agreement included a legal process, through adjudications, to agree up to £80.0m of identified compensation events, recover costs to date and eliminate a potential liability to National Grid for completing the works.

 

To date, we have recorded a charge to the income statement of £49.3m reflecting the cash position at termination. As outlined at our interim results in August, under the terms of the agreement, the cumulative outcome for us of these adjudications ranged from an additional cash receipt of up to a maximum of £50.0m to a cash payment of up to a maximum of £57.3m.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANAAFLEFFFA
Date   Source Headline
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSCostain returns to FTSE 250
25th Feb 20266:00 pmRNSAshtead Group
24th Feb 20263:59 pmRNSDirector Declaration
23rd Feb 20262:59 pmRNSHolding(s) in Company
20th Feb 20264:19 pmRNSHolding(s) in Company
18th Feb 20261:55 pmRNSHolding(s) in Company
9th Feb 20262:50 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.